IDYA:NASDAQ, IDEAYA Biosciences, Inc.

IDYA stock overview

IDEAYA Biosciences, Inc. (IDYA:NASDAQ) closed at $33.81 on October 19, 2026, up 2.92% on the day. The stock trades 20.8% below its 52-week high of $42.68 and 26.1% above its 52-week low of $26.81. Over the past year, it gained 10.8%. IDEAYA Biosciences, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$33.81
Day change
+2.92%
Volume
766,366
Average volume
784,382
Market cap
3B+
52-week range
$26.81 – $42.68
50-day average
$37.89
200-day average
$34.12

Price action over the past year

In 252 trading sessions since October 17, 2025, IDYA closed higher on 122 days (48%). Its best day was June 8, 2026 (+11.28%) and its worst was June 9, 2026 (-10.83%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

IDYA news

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences Inc an oncology-focused medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.

Similar stocks

Find more stocks like IDYA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.